The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New leadership moves, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Leadership Trends
See who's moving and how much in your market
No credit card required Weekly executive digest
Freenome Establishes Interim Office of the CEO With Riley Ennis, Co Founder, Taking Lead Role
PRIVATESep 25, 2024•over 1 year ago
Company
Freenome
BrisbaneBiotechnology
Description
Mike Nolan has resigned as chief executive officer (CEO) of Freenome for personal reasons. The Board of Directors has established an interim Office of the CEO, led by Freenome's co-founder Riley Ennis, with assistance from Douglas VanOort, a Freenome Board member and former chairman of the board and CEO at NeoGenomics, to provide leadership continuity and operational management during the transition. The board will be selecting a successor to guide the organization toward commercialization and increasing its public presence as Freenome focuses on bringing blood-based screening to patients.
Company Information
Company
Freenome
Location
Brisbane, California, United States
About
Freenome is breaking barriers to early cancer detection with a suite of blood-based tests built on its multiomics platform. The company recognizes that no single technology can identify every cancer due to the disease's inherent heterogeneity. Freenome's multimodal approach combines molecular biology and assays with computational biology, machine learning and multiple data types to tune into cancer's subtlest cues, even at the earliest stages of the disease.
BrisbaneBiotechnology